Immune evaluation with skin tests in prostatic carcinoma.
By intradermal injection of 3 recall antigens, nonspecific secondary cell immunity was studied in 61 patients with prostatic carcinomas. Immune competence is lower in patients with metastatic disease. Skin tests have a short-term prognostical value.
D000328:Adult; D000368:Aged; D000941:Antigens; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000276:immunology*; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology
D000941:Antigens